Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MechanoSignaling

Financiado

Cerrado

Predicting cardiovascular regeneration integrating mechanical cues and signalin...

Predicting cardiovascular regeneration integrating mechanical cues and signaling pathways The key challenge in regenerative medicine is to re-establish a physiological tissue organization as this is conditional for proper tissue functionality. In the cardiovascular field, tissue engineering of blood vessels and heart v... ver más

31/01/2026

TU/e

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

TECHNISCHE UNIVERSITEIT EINDHOVEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-10-09

ERC-2018-STG: ERC Starting Grant

I+D

Cerrada hace 7 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

TU/e

1.50M€ | Lider

MAHOU-SAN MIGUEL

519.23K€ | Participante

Proyectos interesantes

G-Valve

Medical Technol...

Materials Scien...

175K€ Cerrado

ANGIOSCAFF

Medical Technol...

Materials Scien...

15M€ Cerrado

BES-2014-067838

Medical Technol...

Materials Scien...

88K€ Cerrado

SAF2013-42528-R

Medical Technol...

Materials Scien...

242K€ Cerrado

EIN2020-112443

Medical Technol...

Materials Scien...

10K€ Cerrado

PRE2019-088735

Medical Technol...

Materials Scien...

98K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 87 meses Fecha Inicio: 2018-10-09
Fecha Fin: 2026-01-31

Líder del proyecto

TECHNISCHE UNIVERSITEIT EINDHOVEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The key challenge in regenerative medicine is to re-establish a physiological tissue organization as this is conditional for proper tissue functionality. In the cardiovascular field, tissue engineering of blood vessels and heart valves requires the development of a tri-laminar structure. Previous attempts to establish this organization have been mainly trial-and-error based. Therefore, to force breakthroughs and accelerate clinical translation, computational modeling is critical to understand and predict the process of neo-tissue regeneration starting from non-living biodegradable materials (i.e. scaffolds). The main drivers of regeneration are (1) hemodynamic loads that trigger mechanically-driven tissue growth and remodeling, and (2) signaling interactions between cells that control the emergence of global tissue organization (e.g. layering of vessels and valves). While the first aspect currently receives vast attention, the modeling of cell signaling in the context of tissue engineering remains an unexplored area. In this project, I aim to obtain a mechanistic understanding of how a critical pathway in the cardiovascular system, i.e. the Notch signaling pathway, drives the emergence of global tissue organization while interacting with mechanical cues. I will adopt a unique, multi-disciplinary approach, where quantitative in vitro experiments will be performed to inform novel multi-scale computational models of Notch signaling and its consequences on regeneration. I will leverage these models to understand and predict in vivo regeneration of engineered cardiovascular tissues starting from various initial conditions. If successful, this project will have a tremendous impact on the development of rational guidelines for ensuring functional tissue regeneration, which represents a breakthrough towards creating cardiovascular replacements that are superior to current treatment options. Moreover, it enables me to start my own independent research group in this field.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores